Literature DB >> 19144372

Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex.

Jason O'Donnell1, Kenneth A Taylor, Michael S Chapman.   

Abstract

Adeno-associated virus serotype 2 (AAV-2) is a leading candidate vector for gene therapy. Cell entry starts with attachment to a primary receptor, Heparan Sulfate Proteoglycan (HSPG) before binding to a co-receptor. Here, cryo-electron microscopy provides direct visualization of the virus-HSPG interactions. Single particle analysis was performed on AAV-2 complexed with a 17 kDa heparin fragment at 8.3 A resolution. Heparin density covers the shoulder of spikes surrounding viral 3-fold symmetry axes. Previously implicated, positively charged residues R(448/585), R(451/588) and R(350/487) from another subunit cluster at the center of the heparin footprint. The footprint is much more extensive than apparent through mutagenesis, including R(347/484), K(395/532) and K(390/527) that are more conserved, but whose roles have been controversial. It also includes much of a region proposed as a co-receptor site, because prior studies had not revealed heparin interactions. Heparin density bridges over the viral 3-fold axes, indicating multi-valent attachment to symmetry-related binding sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144372      PMCID: PMC2684845          DOI: 10.1016/j.virol.2008.11.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  67 in total

1.  CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.

Authors:  Christian Kurzeder; Bernd Koppold; Georg Sauer; Stefan Pabst; Rolf Kreienberg; Helmut Deissler
Journal:  Int J Mol Med       Date:  2007-02       Impact factor: 4.101

2.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

Review 3.  Packaging systems for adeno-associated virus vectors.

Authors:  J P Trempe
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

4.  Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.

Authors:  M I Phillips
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

5.  SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields.

Authors:  J Frank; M Radermacher; P Penczek; J Zhu; Y Li; M Ladjadj; A Leith
Journal:  J Struct Biol       Date:  1996 Jan-Feb       Impact factor: 2.867

Review 6.  Adenovirus and adeno-associated virus as vectors for gene therapy.

Authors:  K I Berns; C Giraud
Journal:  Ann N Y Acad Sci       Date:  1995-11-27       Impact factor: 5.691

7.  Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.

Authors:  T Jackson; F M Ellard; R A Ghazaleh; S M Brookes; W E Blakemore; A H Corteyn; D I Stuart; J W Newman; A M King
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Intra- and extracellular immunization against HIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody.

Authors:  J D Chen; Q Yang; A G Yang; W A Marasco; S Y Chen
Journal:  Hum Gene Ther       Date:  1996-08-20       Impact factor: 5.695

9.  Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.

Authors:  Magalie Penaud-Budloo; Caroline Le Guiner; Ali Nowrouzi; Alice Toromanoff; Yan Chérel; Pierre Chenuaud; Manfred Schmidt; Christof von Kalle; Fabienne Rolling; Philippe Moullier; Richard O Snyder
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

10.  Heparin structure and interactions with basic fibroblast growth factor.

Authors:  S Faham; R E Hileman; J R Fromm; R J Linhardt; D C Rees
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728

View more
  64 in total

1.  Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B).

Authors:  Thomas F Lerch; Michael S Chapman
Journal:  Virology       Date:  2011-12-09       Impact factor: 3.616

2.  Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20.

Authors:  Dustin M McCraw; Jason K O'Donnell; Kenneth A Taylor; Scott M Stagg; Michael S Chapman
Journal:  Virology       Date:  2012-06-09       Impact factor: 3.616

3.  Structure of AAV-DJ, a retargeted gene therapy vector: cryo-electron microscopy at 4.5 Å resolution.

Authors:  Thomas F Lerch; Jason K O'Donnell; Nancy L Meyer; Qing Xie; Kenneth A Taylor; Scott M Stagg; Michael S Chapman
Journal:  Structure       Date:  2012-06-21       Impact factor: 5.006

Review 4.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

5.  Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.

Authors:  Sanford L Boye; Antonette Bennett; Miranda L Scalabrino; K Tyler McCullough; Kim Van Vliet; Shreyasi Choudhury; Qing Ruan; James Peterson; Mavis Agbandje-McKenna; Shannon E Boye
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

6.  Capsid antibodies to different adeno-associated virus serotypes bind common regions.

Authors:  Brittney L Gurda; Michael A DiMattia; Edward B Miller; Antonette Bennett; Robert McKenna; Wendy S Weichert; Christian D Nelson; Wei-jun Chen; Nicholas Muzyczka; Norman H Olson; Robert S Sinkovits; John A Chiorini; Sergei Zolotutkhin; Olga G Kozyreva; R Jude Samulski; Timothy S Baker; Colin R Parrish; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

7.  Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus.

Authors:  Fuming Zhang; Javier Aguilera; Julie M Beaudet; Qing Xie; Thomas F Lerch; Omar Davulcu; Wilfredo Colón; Michael S Chapman; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-08-28       Impact factor: 3.162

Review 8.  Modern uses of electron microscopy for detection of viruses.

Authors:  Cynthia S Goldsmith; Sara E Miller
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

9.  Porcine Circovirus 2 Uses a Multitude of Weak Binding Sites To Interact with Heparan Sulfate, and the Interactions Do Not Follow the Symmetry of the Capsid.

Authors:  Sonali Dhindwal; Bryant Avila; Shanshan Feng; Reza Khayat
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.

Authors:  Angela C Bradshaw; Alan L Parker; Margaret R Duffy; Lynda Coughlan; Nico van Rooijen; Veli-Matti Kähäri; Stuart A Nicklin; Andrew H Baker
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.